The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics

J Mol Med (Berl). 2014 Nov;92(11):1129-38. doi: 10.1007/s00109-014-1208-4. Epub 2014 Oct 11.

Abstract

A growing body of evidence indicates that microRNA23b (miR23b) is pleiotropic-it plays important roles in regulating physiological functions of cells, in regulating differentiation of cells and in regulating cellular immune responses. Our review of the literature showed that dysregulation of miR23b expression is implicated in the disruption of these cellular mechanisms and development of diseases such as cancer. MiR23b dysregulation appears to do this by modulating the expression level of candidate gene products involved in a network of signaling pathways including TGF-beta and Notch pathways that govern malignant properties of cancer cells such as motility and invasiveness. More recently, miR23b regulation of gene expression has also been associated with cancer stem cells and chemoresistance. Our review covers miR23b's role in immunity, endothelial function, differentiation, and cancer as well as its potential for translation into future cancer diagnostics and therapeutics.

Keywords: Cancer stem cells; MiR23b; Signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation
  • Endothelial Cells / cytology
  • Female
  • Gene Expression Regulation*
  • Homeostasis
  • Humans
  • Immune System
  • Male
  • Mice
  • MicroRNAs / metabolism*
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplastic Stem Cells / cytology
  • Protein Biosynthesis
  • Receptors, Notch / metabolism
  • Signal Transduction*
  • Transforming Growth Factor beta / metabolism
  • Translational Research, Biomedical

Substances

  • MIRN23a microRNA, human
  • MicroRNAs
  • Receptors, Notch
  • Transforming Growth Factor beta